Refresh

GlaxoSmithKline Pharmaceuticals Ltd. - Research Center

500660 GLAXO Group (A) BSE data
Back to Company

Results

Statement

More

Profit & Loss Account
(Rs crore)
Mar ' 24 Mar ' 23 Mar ' 22 Mar ' 21 Mar ' 20
Income

Operating income

3,407.25 3,216.34 3,217.51 2,920.48 3,224.68
Expenses

Material consumed

1,296.04 1,255.99 1,300.39 1,252.47 1,308.95

Manufacturing expenses

29.64 103.44 121.30 108.04 33.36

Personnel expenses

624.39 594.99 610.23 616.16 628.55

Selling expenses

- - - - 138.23

Adminstrative expenses

556.53 462.50 429.76 346.03 457.13

Expenses capitalised

- - - - -

Cost of sales

2,506.60 2,416.92 2,461.68 2,322.70 2,566.23

Operating profit

900.65 799.43 755.83 597.77 658.45

Other recurring income

123.48 101.51 76.22 110.19 77.56

Adjusted PBDIT

1,024.13 900.94 832.04 707.96 736.01

Financial expenses

1.80 1.81 1.99 3.53 6.34

Depreciation

69.68 65.77 68.19 78.60 82.68

Other write offs

- - - - -

Adjusted PBT

952.65 833.36 761.87 625.83 646.99

Tax charges

224.35 227.69 396.87 166.54 212.45

Adjusted PAT

728.30 605.67 365.00 459.29 434.55

Non recurring items

-143.62 2.08 1,325.53 -101.72 -324.49

Other non cash adjustments

- - - - -

Reported net profit

584.69 607.75 1,690.53 357.57 110.05

Earnigs before appropriation

1,412.81 2,352.77 2,253.24 1,240.34 1,291.23

Equity dividend

542.10 1,524.66 508.22 677.62 269.17

Preference dividend

- - - - -

Dividend tax

- - - - 69.64

Retained earnings

870.71 828.12 1,745.02 562.71 952.41
Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2024 Rediff.com